On August 25, 2021 NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), reported that it will participate in the German Fall conference taking place from September 6 to September 7, 2021 (Press release, NOXXON, AUG 25, 2021, View Source [SID1234586888]). The capital market conference for small and mid-cap companies organized by Equity Forum will take place in the form of virtual one-on-one meetings.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference aims at bringing together public company representatives across sectors with investors, analysts, financial journalists, intermediaries and financial industry experts. Around 100 companies will participate in this year’s summit to present their equity story. NOXXON’s CEO, Aram Mangasarian, will be available for meetings on both conference days. To schedule a meeting please contact the conference organizer or send an email to [email protected].